help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakane, N.
Right arrow Articles by Nakagaw, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sakane, N.
Right arrow Articles by Nakagaw, Y.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 4 1400
Copyright © 1998 by The Endocrine Society


Letters to the Editor

Serum Leptin Levels in a Patient with Pheochromocytomah

Naoki Sakane and Toshihide Yoshida

Kyoto Prefectural University of Medicine Kyoto 602, Japan

Takaaki Mizutani and Yuuji Nakagaw

Ayabe Municipal Hospital Ayabe 623, Japan

We read with great interest the report of Masuzaki et al. (1), which showed that serum leptin levels were increased in patients with Cushing’s syndrome. However, serum leptin levels in a patient with pheochromocytoma, another adrenal tumor, were not described.

A 72-yr-old man complaining of episodic headaches, nausea, palpitations, and perspiration was referred to our department in October 1997. Physical examination showed that the patient was agitated and had striking peripheral vasoconstriction. Blood pressure varied between 240/130 and 80/40 mm Hg; the patient did not have orthostatic hypotension. Plasma noradrenaline and adrenaline levels were increased (2.20 ng/mL and 0.86 ng/mL, respectively), although serum cortisol and aldosterone levels were normal. Twenty-four-hour urinary noradrenaline and adrenaline were also increased (882 µg/day and 138 µg/day, respectively). A tentative diagnosis of pheochromocytoma was made. Computed tomography of the abdomen showed a mass measuring approximately 4 cm in diameter in the left adrenal gland. Pathological examination after left-sided adrenalectomy were compatible with pheochromocytoma. After surgery, the patient had no symptoms and was normotensive. Although serum leptin levels were low before surgery, serum leptin levels were increased with diurnal rhythms 1 month after surgery (Table 1Go).


View this table:
[in this window]
[in a new window]
 
Table 1. Cathecholamine and serum leptin levels in a patient with pheochromocytoma

 
It was recently reported that norepinephrine decreases ob gene expression in vitro (2) and in vivo (3), and also decreases circulating leptin levels in animals (4, 5). Therefore, high serum norepinephrine levels, which pheochromocytoma produces, might decrease serum leptin levels.

Footnotes

Address correspondence to: Toshihide Yoshida, First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kamikyo-ku, Kyoto 602, Japan.

Received December 31, 1997.

References

  1. Masuzaki H, Ogawa Y, Hosoda K, et al. 1997 Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing’s syndrome. J Clin Endocrinol Metab. 82:2542–2547.[Abstract/Free Full Text]
  2. Kosaka A, Yamada K, Kuzuya H. 1996 Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3–L1 adipocytes. Diabetes. 45:1744–1749.[Abstract]
  3. Trayhurn P, Thomas MEA, Durcan JS, et al. 1995 Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J. 311:729–733.
  4. Hardie LJ, Rayner DV, Holemes S, et al. 1996 Circulating leptin levels are modulated by fasting, cold exposure, and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun. 25:60–665.[CrossRef]
  5. Gettys TW, Harkness PJ, Watson PM. 1996 The ß3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology. 137:4054–4057.[Abstract]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakane, N.
Right arrow Articles by Nakagaw, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sakane, N.
Right arrow Articles by Nakagaw, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals